• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一名前列腺癌患者行 PET/CT 成像检查时,偶然发现其患有硬纤维瘤,该肿瘤摄取 18F-Fluciclovine。

Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer.

机构信息

From the Division of Diagnostic Imaging.

Departments of Abdominal Imaging.

出版信息

Clin Nucl Med. 2021 Apr 1;46(4):355-357. doi: 10.1097/RLU.0000000000003459.

DOI:10.1097/RLU.0000000000003459
PMID:33323736
Abstract

A 74-year-old man with biochemical recurrent prostate cancer underwent 18F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. 18F-fluciclovine PET/CT imaging demonstrated incidental focal heterogeneous increased 18F-fluciclovine uptake corresponding to a soft tissue nodule within the musculature of the left anterior abdominal wall. Subsequent ultrasound-guided biopsy of the lesion revealed histopathology compatible with a desmoid tumor. Consequently, the patient underwent surgical resection with wide local excision of the lesion.

摘要

一位 74 岁男性因生化复发前列腺癌接受 18F-氟丁氨酸 PET/CT 检查以进行分期,以确定后续治疗策略。18F-氟丁氨酸 PET/CT 成像显示偶然发现左前腹壁肌肉内软组织结节存在局灶性异质性 18F-氟丁氨酸摄取增加。随后对病变进行超声引导活检显示组织病理学符合硬纤维瘤。因此,患者接受了手术切除,广泛局部切除病变。

相似文献

1
Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer.在一名前列腺癌患者行 PET/CT 成像检查时,偶然发现其患有硬纤维瘤,该肿瘤摄取 18F-Fluciclovine。
Clin Nucl Med. 2021 Apr 1;46(4):355-357. doi: 10.1097/RLU.0000000000003459.
2
Incidental 18F-Fluciclovine Uptake in a Warthin Tumor of the Parotid Gland in a Patient Undergoing PET/CT Imaging for Biochemical Recurrent Prostate Cancer.患者因生化复发前列腺癌行 PET/CT 影像学检查时,偶然发现腮腺沃辛瘤摄取 18F-Fluciclovine。
Clin Nucl Med. 2020 Apr;45(4):e208-e210. doi: 10.1097/RLU.0000000000002938.
3
Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan.18F-氟丁氨酸 PET/CT 扫描摄取增加的转移性男性乳腺癌。
Clin Nucl Med. 2018 Jan;43(1):23-24. doi: 10.1097/RLU.0000000000001893.
4
18F-Fluciclovine Uptake by an Incidentally Detected Hepatocellular Carcinoma in a Case of Biochemically Recurrent Prostate Cancer.18F-氟代脱氧葡萄糖摄取偶然检测到的前列腺癌生化复发患者的肝细胞癌。
Clin Nucl Med. 2018 Sep;43(9):695-696. doi: 10.1097/RLU.0000000000002176.
5
Uptake of 18F-Fluciclovine in Paget Disease.18F-氟柳氯维在佩吉特病中的摄取。
Clin Nucl Med. 2019 Nov;44(11):e614-e616. doi: 10.1097/RLU.0000000000002670.
6
Differential 18F-FDG and 18F-Fluciclovine Uptake Pattern in a Patient With Poorly Differentiated Adenocarcinoma of the Lung and Prostate Cancer Biochemical Recurrence.18F-FDG 和 18F-Fluciclovine 摄取模式在一位患有低分化肺腺癌和前列腺癌生化复发患者中的差异。
Clin Nucl Med. 2020 Jan;45(1):e63-e64. doi: 10.1097/RLU.0000000000002781.
7
Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer.在接受 18F-氟丁醇 PET/CT 成像评估前列腺癌的患者中检测到偶然发现的中枢神经系统脑膜瘤的发生率。
Nucl Med Commun. 2021 Jul 1;42(7):755-762. doi: 10.1097/MNM.0000000000001389.
8
Poorly Differentiated Neuroendocrine Tumor With 18F-Fluciclovine Uptake in a Patient With Metastatic Castrate-Resistant Prostate Cancer.转移性去势抵抗性前列腺癌患者的乏氧氟代脱氧葡萄糖摄取的低分化神经内分泌肿瘤。
Clin Nucl Med. 2021 May 1;46(5):e282-e285. doi: 10.1097/RLU.0000000000003408.
9
Incidental Detection of Urothelial Carcinoma on 18F-Fluciclovine PET/CT.18F-氟丁醇 PET/CT 偶然发现尿路上皮癌。
Clin Nucl Med. 2021 Feb 1;46(2):e114-e115. doi: 10.1097/RLU.0000000000003342.
10
18F-Fluciclovine Uptake in Acute Appendicitis.18F-氟丁氨酸摄取在急性阑尾炎中的应用。
Clin Nucl Med. 2020 Oct;45(10):e453-e454. doi: 10.1097/RLU.0000000000003210.

引用本文的文献

1
Clinical and imaging features of desmoid tumors of the extremities.肢体硬纤维瘤的临床及影像学特征
World J Clin Cases. 2021 Oct 16;9(29):8710-8717. doi: 10.12998/wjcc.v9.i29.8710.